stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Enliven Therapeutics IncELVN
$44.580.75%0.33
Dopo l'orario di chiusura: 44.63+0.05 +0.11%

Enliven Therapeutics Inc (ELVN)

Date: 2026-11-02 16:00O: 44.48H: 45.06L: 43.23C: 44.58Vol: 708.7k
Precedente Chiudi:
$44.25
Aprire:
$44.48
Volume 24 ore:
708,723
Volume relativo:
0.38
Capitalizzazione di mercato:
$3.27B
Reddito:
-
Utile/perdita netta:
-$98.78M
Rapporto P/E:
-
EPS:
-$1.66
Flusso di cassa netto:
-$65.60M
1W Prestazione:
+7.45%
1M Prestazione:
-5.09%
6M Prestazione:
+6.91%
1Y Prestazione:
+90.35%
Intervallo 1D:
$43.23$45.06
Intervallo di 1 settimana:
$41.52$45.87
Portata 52W:
$14.79$62.32

Profilo aziendale di Enliven Therapeutics Inc (ELVN)

Nome
Enliven Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
720-647-8519
Indirizzo
6200 LOOKOUT ROAD, BOULDER, USA
Dipendente
60
X
-
Prossima data di guadagno
2026-11-11
Ultimi documenti SEC
SEC
Discussioni di ELVN su X
X

Confronta ELVN con VRTX, REGN, MRNA, ARGX, ONC

AzioniCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
ELVN
Enliven Therapeutics Inc
$3.27B$0-$105.93M-$67.04M-$1.66
VRTX
Vertex Pharmaceuticals Inc
$140.94B$12.59B$4.41B$3.80B$16.87
REGN
Regeneron Pharmaceuticals Inc
$99.46B$16.90B$4.82B$3.83B$41.04
MRNA
Moderna Inc
$88.17B$2.23B-$3.15B-$1.24B-$8.15
ARGX
Argen X Se Adr
$55.03B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$40.86B$6.13B$655.71M$1.33B$4.48

Enliven Therapeutics Inc Azioni (ELVN) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-10-02IniziatoMorgan StanleyOverweight
2026-10-01IniziatoJP MorganOverweight
2026-08-18IniziatoBarclaysOverweight
2026-08-18IniziatoWilliam BlairOutperform

Enliven Therapeutics Inc Azioni (ELVN) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)--0.00--
Research and development USD (M)85.8680.7864.5718.9438.44
Operating expenses USD (M)119.66104.5583.5334.2751.44
Operating income USD (M)-119.66-104.55-83.530.73-51.44
Income before tax USD (M)---71.581.58-
Income tax expense USD (M)0.000.230.000.09-
Net income USD (M)-103.69-89.02-71.581.49-51.38
Basic EPS USD/shares-1.83-1.89-2.010.06-
Diluted EPS USD/shares-1.83-1.89-2.010.06-
Basic weighted shares shares (M)56.6647.0735.5526.29-
Diluted weighted shares shares (M)56.6647.0735.5526.39-

Enliven Therapeutics Inc Azioni (ELVN) insider trading

  • Hohl BenjaminOct 19 '26
    CHIEF FINANCIAL OFFICER
    Transazione
    Sale
    Costo
    $38.48
    #Azioni
    6,018
    Valore ($)
    231,546
    #Azioni Totale
    38,000
  • Director
    Transazione
    Proposed Sale
    Costo
    $37.32
    #Azioni
    15,000
    Valore ($)
    559,800
    #Azioni Totale
    0
  • Hohl BenjaminOct 19 '26
    CHIEF FINANCIAL OFFICER
    Transazione
    Option Exercise
    Costo
    $14.85
    #Azioni
    6,018
    Valore ($)
    89,367
    #Azioni Totale
    44,018
  • CHIEF MEDICAL OFFICER
    Transazione
    Sale
    Costo
    $38.47
    #Azioni
    5,000
    Valore ($)
    192,342
    #Azioni Totale
    25,000
  • CHIEF MEDICAL OFFICER
    Transazione
    Option Exercise
    Costo
    $2.48
    #Azioni
    5,000
    Valore ($)
    12,400
    #Azioni Totale
    30,000
  • Director
    Transazione
    Sale
    Costo
    $46.67
    #Azioni
    13,000
    Valore ($)
    606,719
    #Azioni Totale
    0
  • Director
    Transazione
    Option Exercise
    Costo
    $15.47
    #Azioni
    13,000
    Valore ($)
    201,110
    #Azioni Totale
    13,000
  • JEFFREY GARLANDOct 01 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $46.67
    #Azioni
    13,000
    Valore ($)
    606,719
    #Azioni Totale
    0
  • CHIEF MEDICAL OFFICER
    Transazione
    Sale
    Costo
    $50.35
    #Azioni
    5,000
    Valore ($)
    251,754
    #Azioni Totale
    25,000
  • CHIEF MEDICAL OFFICER
    Transazione
    Option Exercise
    Costo
    $2.48
    #Azioni
    5,000
    Valore ($)
    12,400
    #Azioni Totale
    30,000
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
Hohl BenjaminCHIEF FINANCIAL OFFICEROct 19 '26Sale$38.486,018231,54638,000
Collins Helen LouiseDirectorOct 19 '26Proposed Sale$37.3215,000559,8000
Hohl BenjaminCHIEF FINANCIAL OFFICEROct 19 '26Option Exercise$14.856,01889,36744,018
Collins Helen LouiseCHIEF MEDICAL OFFICEROct 19 '26Sale$38.475,000192,34225,000
Collins Helen LouiseCHIEF MEDICAL OFFICEROct 19 '26Option Exercise$2.485,00012,40030,000
Garland J. ScottDirectorOct 01 '26Sale$46.6713,000606,7190
Garland J. ScottDirectorOct 01 '26Option Exercise$15.4713,000201,11013,000
JEFFREY GARLANDDirectorOct 01 '26Proposed Sale$46.6713,000606,7190
Collins Helen LouiseCHIEF MEDICAL OFFICERSep 17 '26Sale$50.355,000251,75425,000
Collins Helen LouiseCHIEF MEDICAL OFFICERSep 17 '26Option Exercise$2.485,00012,40030,000

Enliven Therapeutics Inc Borsa (ELVN) Ultime notizie

Oct 27, 2026
Oct 27, 2026
Oct 23, 2026
Oct 23, 2026
Oct 22, 2026
Oct 22, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 21, 2026
Oct 19, 2026
Oct 19, 2026
Oct 17, 2026
Oct 17, 2026
Oct 16, 2026
Oct 16, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 12, 2026
Oct 05, 2026
Oct 05, 2026
Oct 01, 2026
Oct 01, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 22, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 17, 2026
Sep 17, 2026
Sep 10, 2026
Sep 10, 2026
Sep 08, 2026
Sep 08, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 31, 2026
Aug 30, 2026
Aug 30, 2026
Aug 25, 2026
Aug 25, 2026
Aug 21, 2026
Aug 21, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 20, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026

Simile a ELVN